Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2014 Nov 18;9(11):e114175. doi: 10.1371/journal.pone.0114175

Correction: Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)

The PLOS ONE Staff
PMCID: PMC4236170

There is an error in affiliation 3 for author Liang-Yu Lin. Affiliation 3 should be: Institute of Pharmacology, National Yang-Ming University and Division of Endocrinology and Metabolism, Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Reference

  • 1. Liu P-Y, Lin L-Y, Lin H-J, Hsia C-H, Hung Y-R, et al. (2013) Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study). PLoS ONE 8(10): e76298 doi:10.1371/journal.pone.0076298 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES